Data as of Q4 2025 (Dec 31, 2025)
โณ
Showing Q4 2023 data
TRV GP III, LLC's Q4 2025 filing not yet available. Expected by Feb 14, 2026.

TRV GP III, LLC

โ€ขCIK: 1637299โ€ขFiling: Q4 2023

**TRV GP III, LLC** manages a concentrated portfolio with current Assets Under Management of $6M. The fund exhibits a highly focused strategy, evidenced by its single top holding in PLRX, representing $6.1M of the total AUM. This significant single-stock allocation suggests a deep conviction in the underlying asset's near-term trajectory. Investors should note the current concentration risk inherent in this structure.

Total AUM
$6.1M
QoQ Performance
N/A
Positions
1
Top 10 Concentration
100.0%
Latest Filing
Q4 2023

Top Holdings Allocation

PLRX
PLRX100.0%

๐Ÿ“ˆ Biggest Buys

PLRX
PLIANT THERAPEUTICS, INC.
NEW
100.0% of portfolio

๐Ÿ“‰ Biggest Sells

No reductions this quarter

Sector Breakdown

Other100.0%